Page last updated: 2024-09-04

tipifarnib and Sepsis

tipifarnib has been researched along with Sepsis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirai, S; Hisaka, S; Ichinose, F; Kaneki, M; Shirozu, K; Tanaka, T1

Other Studies

1 other study(ies) available for tipifarnib and Sepsis

ArticleYear
Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
    Shock (Augusta, Ga.), 2014, Volume: 42, Issue:6

    Topics: Animals; Caspase 3; Cell Survival; Cytokines; Endotoxemia; Enzyme Inhibitors; Farnesyltranstransferase; Galactosamine; Gene Expression Regulation; Hepatocytes; Inflammation; Interleukin-6; Lipids; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Quinolones; Sepsis; Tumor Necrosis Factor-alpha

2014